We have investigated interstitial deletions of chromosome 8 in 70 colorectal carcinomas and 11 colonic adenomas using 11 microsatellite markers, including eight spanning the centromeric region of chromosome 8p (p11.2-p12). Allelic loss or imbalance was observed in 38 (54%) cancers and four (36%) adenomas. Twenty-eight (40%) of the cancers had deletions of 8p11.2-p12. Two distinct and independent regions of interstitial loss were found within this region. Fluorescent in situ hybridization, using an a satellite repeat probe to the centromere of 8p and two probes to the P1 region, was performed in four tumours that demonstrated allelic imbalance. Localized heterozygous deletions were con®rmed in all four tumours. Eleven (16%) cancers had localized deletion in the region ANK-1 to D8S255 (P1) and a further eleven (16%) cancers had a less well localized deletion in the region de®ned by the markers D8S87 to D8S259 (P2). Loss of both centromeric loci was identi®ed in a further six (9%) tumours. A functional signi®cance for these two deletion regions was sought by correlation with primary and secondary tumour characteristics. Isolated P2 deletion was associated with`early' T1 cancers (2p=0.0002), and were also identi®ed in 3/11 adenomas. Conversely, interstitial deletions of the P1 locus were more frequently seen in`locally invasive' T3/4 cancers (2p=0.015), and isolated P1 deletions were also associated with the presence of liver metastases (2p=0.016). Our data provide evidence of at least two genes within the 8p11.2-p12 region, mutations in which may confer dierent and independent roles in the pathogenesis of colorectal cancer.
Introduction
Colorectal cancer is the third most common malignancy worldwide (Shike et al., 1990) and is the second leading cause of cancer deaths in the United States following lung cancer (American Cancer Society, 1990; Boring et al., 1992) . Advances in the molecular understanding of colorectal cancer have facilitated characterization of the genotype with the genes most commonly involved being DCC, APC, K-ras and p53. Mutations in these genes have been implicated as occurring during key stages of the adenoma-carcinoma sequence (Fearon et al., 1987; Fearon and Vogelstein, 1990) , but epidemiological data indicates that the list of genes involved in colorectal tumorigenesis is still incomplete (Vogelstein et al., 1988 (Vogelstein et al., , 1989 . Allelotyping has implicated other putative tumour suppressor gene loci in colorectal carcinogenesis (Vogelstein et al., 1988 (Vogelstein et al., , 1989 and identi®ed a number of regions on the genome where such genes may lie. Deletions on chromosome 8p are the most frequent sites of loss of heterozygosity (LOH) to which candidate tumour suppressor genes (TSGs) have yet to be assigned (Wasylyshyn et al., 1991; Emi et al., 1992; Cunningham et al., 1993; Fujiwara et al., 1993; Chang et al., 1994; Yaremko et al., 1994) . LOH was found at 8p22-p23.2 and 8p11.22-p21.3 by Fujiwara et al. (1993) and at 8p23.1-pter and 8p21 by , and a candidate tumour suppressor gene, termed PDGF-receptor beta-like tumour suppressor, PRLTS, was isolated from the 8p21.3-p22 region (Fujiwara et al., 1995) . How the PRTLS gene might in¯uence colorectal cancer development has yet to be determined.
Some association between chromosome 8p deletions and tumour behaviour has been reported. Fujiwara et al. (1993) identi®ed an association between the presence of 8p deletions and advanced colorectal cancer, but no correlation between the two distinct regions of 8p deletion and tumour phenotype. This early report was supported by Cunningham et al. (1994) , who detected a relative paucity of 8p deletions (10%) in a series of premalignant colorectal adenomas. Kelemen et al. (1994) has subsequently identi®ed an association between deletions of 8p21-p22 with lymphatic, vascular and perineural microinvasion, but this study was restricted to 15 colorectal tumours. Recently, functional evidence for a TSG(s) at the 8p22-p23 region has been demonstrated (Gustafson et al., 1996) using microcell-mediated monochromosome 8 transfer in three colorectal cell lines. To date no clear association between individual deletion sites on chromosome 8p and tumour behaviour has been reported. Such an association would imply a function for the inactivated TSG(s) and so would support further detailed mapping and cloning studies of the particular regions.
Whilst the 8p11.2-p12 region has received little attention in colorectal cancer studies, it has been a focus of LOH analysis in prostate tumours. Recent studies in prostate cancer (Macoska et al., 1995) , including our own (Crundwell et al., 1996) have identi®ed two regions of frequent interstitial deletions de®ned by the markers ANK-1 to D8S87 (8p11.2-p.12), and the markers D8S259 to D8S505 (8p12). In our study of prostate cancers, a weak relationship between interstitial deletions on 8p and tumour behaviour was identi®ed. Deletions in the ANK-1 to D8S87 region were associated with tumours which had metastasized. Conversely deletions in the D8S259 to D8S505 region were frequently seen in early prostate cancer (Crundwell et al., 1996) . More detailed investigation of this ®nding was restricted as wide resection of prostatic cancer is rarely performed, limiting the histological assessment of the tumour samples. We therefore proceeded to explore this ®nding in colorectal cancers, in which wide resection of the primary tumour facilitates accurate histological assessment of the tumour.
This study set out to produce a deletion map of the 8p11.2-p12 region in 70 cases of colorectal cancer using highly informative microsatellite markers. Correlation with detailed clinicopathological parameters allowed us to assign possible functional signi®cance to the underlying putative tumour suppressor gene(s) for each site of frequent loss of heterozygosity.
Results
Details of the tumour stage, tumour site, grade of dierentiation, gender and age are given in Table 1 . Allelic deletion or imbalance of 8p was identi®ed in 38 (54%) colorectal cancers. Examples of autoradiographs showing LOH and retention of alleles at dierent marker loci in paired constitutional and tumour DNAs are demonstrated in Figure 1 . All tumours were informative for three or more of the eleven polymorphic microsatellite markers.
Regions of interstitial deletion
The positions of the interstitial deletions on chromosome 8p are shown schematically in Figure 2 . Two distinct deletion regions, termed P1 and P2, were identi®ed spanning the region 8p11.2-p12. The P1 deletion was localized between the markers ANK1-D8S255 and the P2 deletion between the markers D8S87-D8S259. Twenty-eight (40%) cancers were found to have deletions of 8p11.2-p12. In six tumours (samples 73, 106, 27, 60, 7 and 52) both the P1 and P2 loci were lost. A further 11 tumours (samples 16, 64, 63, 96, 83, 45, 47, 10, 46, 86 and 9) had localized P1 loss and 11 other tumours (samples 24, 28, 34, 5, 48, 38, 62, 25, 21, 76 and 53) had localized P2 loss. The minimal region of deletion on 8p11.2-p12 in the P1 region was demonstrated in six tumour samples (16, 64, 63, 45, 10 and 46) suggesting the location of a putative tumour suppressor gene between the two markers ANK-1 and D8S255, a region which may be as small as 1 cM (Dib et al., 1996) . The minimal region of deletion in the P2 region is less closely localized in these tumours. Three tumours (5, 28 and 34) place the minimal region of deletion as proximal to D8S259 and distal to D8S87. Tumours 62 and 25 are consistent with this. But tumours 76, 60 and 27 suggest the minimal deletion region is between D8S513 and D8S259, whereas tumour 106 would place the deletion distal to this. Tumours 5 and 38 have deletions that span both these regions. The discrepancy could be explained by the presence of two deletion loci within this (P2) region, but clearly requires more detailed study.
Relative frequency of interstitial deletions
In total, there were 38 (54%) carcinomas with deletions on the short arm of chromosome 8. Telomeric deletions (8p23-p21) were identi®ed in 22/70 (31%) tumours, and in ten of these tumours this was the only 8p deletion identi®ed. Twenty eight (40%) tumours had centromeric loss at 8p11.2-p12 de®ned by the markers ANK-1 to D8S259.
Localized P1 loss was identi®ed in 11/70 (16%) cases and localized P2 loss was also found in 11/70 (16%) cases. Both regions were lost in a further six (9%) tumours of which two appeared to have lost the whole short arm of chromosome 8 (samples 7 and 52). The relative frequency of allelic loss for each primer pair is shown in Figure 3 . The clinical and histological characteristics of the tumour with each combination of interstitial deletion are shown in Table 2 .
Incidence of microsatellite instability
There were nine tumours (13%) in which microsatellite instability was seen. This was identi®ed with six of the 11 microsatellite markers used in the study. In all cases they were isolated events except in sample 12 in which three examples of instability were identi®ed. Tumour sample 12 was obtained from a 52-year-old female patient whose primary tumour was in the caecum. 
Frequency of allelic imbalance
In total, 33 (47%) cancers demonstrated allelic imbalance for one or more markers (see Figure 2) , of which 11 occurred in the P1 region. There is always uncertainty about whether allelic imbalance represents reduplication or deletion of a chromosome arm. As previous studies of breast tumours have suggested there may be reduplication of 8p (Rohen et al., 1995) , we felt this required clearer evaluation in our tumours.
Interphase¯uorescence in situ hybridization (FISH) on four tumours showing allelic imbalance at the P1 region was performed to try to con®rm that the microsatellite ®ndings did represent true regional deletions. Two probes to the P1 region (RMC-08P-044 and RMC-08P-049) were used. Synchronous hybridization with a centromere speci®c a-satellite repeat probe was performed to allow chromosome 8 enumeration. One hundred intact cells were counted per probe per tumour. In each tumour, with both P1 probes, over 50% of cells observed (Table 3) showed a higher chromosome 8 centromere probe count than target probe count indicating allelic loss rather than gain ( Figure 4 ). This corroborated the microsatellite probe ®ndings and justi®ed inclusion of tumours with allelic imbalance in the subsequent correlation analysis between the tumour phenotype and the interstitial deletions.
Correlation of deletions with clinical and pathological features
Crude analysis of tumour stage and 8p deletions showed only correlation between Stage I tumours (Lippincott, 1992 ) and P2 deletion. We then proceeded to look at the relationship between primary and secondary tumour characteristics, and interstitital deletions at the 8p11.2-p12 locus ( Table 2 ). The two Primary tumour characteristics: There were 17 early cancers with invasion limited to the submucosa (T1, n=7) and muscular wall (T2, n=10) of which eight had interstitial deletions (Table 2) . Isolated deletion at the P2 region was seen in four of these 17 tumours. This was signi®cantly dierent from the frequency of isolated P2 deletions in the advanced tumours (4/17 T1-2 tumours vs 1/51 T3-4 tumours; 2p =0.012). All four of these tumours bearing isolated P2 loss were in fact T1 tumours (4/7 T1 tumours vs 1/61 T3-4 tumours; 2p=0.0002). In addition, of the eleven colorectal adenomas screened four (36%) showed LOH of which three were P2 deletions.
Of the 51 primary cancers that had invaded beyond the muscular coat of the bowel wall (T3-4 tumours), 15 had interstitial deletions at the P1 region. There were no P1 deletions seen in those tumours limited to the muscular wall (15/51 of T3-4 vs 0/17 of T1-2 tumours; 2p= 0.015). This contrasted with the relative frequency of P2 deletions (10/51 vs 6/17) and telomeric deletions (18/51 vs 5/17) which showed no correlation with local invasion.
Metastatic disease: Liver metastases (Stage M1) were identi®ed at the time of the primary tumour treatment in 12 patients. Of seven deletions seen in these primary tumours, ®ve were at the P1 region (Table 2 ). In four of these cases, P1 loss was the only deletion identi®ed.
In contrast only three of 56 primary tumours without metastases to the liver had localized P1 loss (2p=0.016).
There was no association between the presence of interstitial deletions and lymph node metastases. No Microinvasion: we did not ®nd any correlation between microinvasion (lymphatic, vascular and perineural) and chromosome 8p loss (10/12 vs 7/10; 2p=0.62). Further subgroup analysis revealed only a weak inverse correlation between microinvasion and isolated P2 loss (4/10 vs 0/12; 2p=0.03). This is in contrast to a previous report on a series of 15 colorectal tumours (Kelemen et al., 1994) .
Discussion
We have identi®ed the presence of interstitial deletions on the short arm of chromosome 8 to be a frequent event in colorectal cancer, occurring in over 50% of malignant tumours. This is consistent with previous published series of colorectal cancers (Vogelstein et al., 1988 (Vogelstein et al., , 1989 Emi et al., 1992; Fujiwara et al., 1993) . This is the ®rst study of colorectal cancer in which two distinct regions of interstitial deletion on chromosome 8p11.2-p12 have been identi®ed. These two centromeric regions, comprising P1 (8p11.2-p12) de®ned by the markers ANK-1 to D8S255 and P2 (8p12) de®ned by the markers D8S87 to D8S259, correspond to the interstitial deletions recently reported in prostate cancer (Macoska et al., 1995; Crundwell et al., 1996) suggesting involvement of the same tumour suppressor genes in the pathogenesis of two quite distinct cancers.
Previous studies of mutational events on chromosome 8 have identi®ed the presence of ampli®cation and reduplication, particularly in breast cancer (Dib et al., 1995; Rohen et al., 1995; A®fy et al., 1996; A®fy and Mark, 1997; Visscher et al., 1997) . PCR analysis with microsatellite probes may not distinguish between cellular heterogeneity in the tumour and ampli®cation of a locus, as either will give rise to allelic imbalance. Allelic imbalance was seen at the P1 and P2 regions in 21 cancers, and complete loss of an allele in these regions were seen in 12 cancers. As allelic imbalance can re¯ect duplication or deletion of a chromosome arm, in situ hybridization was performed to clarify this. FISH revealed no evidence of ampli®cation or reduplication in the four tumours with allelic imbalance at the P1 region, and con®rmed the presence of interstitial deletions in all cases. This result supports the hypothesis that a tumour suppressor gene involved in colorectal carcinogenesis is present at this locus.
The presence of microsatellite instability was identi®ed in 13% of the tumours studied. This is consistent with previous published series ( Konishi et al., 1996) . It is noteworthy that the one tumour in which microsatellite instability was identi®ed with three dierent probes was a right sided lesion in a young patient. These are characteristics known to be associated with hereditary non-polyposis colorectal cancer (Aaltonen et al., 1993; Lynch et al., 1993) . The detailed histological and clinical data available in this study enabled us to perform a rigorous analysis of the relationship between speci®c interstitial deletions and tumour phenotype. We found P1 deletions to be associated with a more advanced tumour phenotype. Speci®cally this deletion was associated with locally invasive (T3-4) tumours, and this ®nding was statistically signi®cant (2p=0.015). P1 deletions were also associated with blood borne metastases, and this mirrored the previous ®ndings in our study of prostatic cancers (Crundwell et al., 1996) .
In contrast to the ®nding in tumours with P1 deletions, P2 deletions were associated with early, minimally invasive (T1) cancers (2p=0.0002). This was also the most common deletion identi®ed in premalignant adenomas, consistent with the clinical ®nding that these histological features often co-exist in the same tumour. In our studies of prostate cancer, P2 deletions were found also to be common in early tumours and were also seen in non-neoplastic benign prostatic hypertrophy (Crundwell et al., 1996) . These data would indicate that gene inactivation at the P2 locus is an early event in prostatic and colorectal carcinogenesis, occurring in the premalignant stage of the disease, whereas gene inactivation at the P1 locus is a later event in carcinogenesis, and may well be involved in cancer progression and the development of metastases. These ®ndings further substantiate the hypothesis that interstitial deletions in these regions were directly in¯uencing tumour behaviour and tumour progression.
The minimal region of deletion in the P2 region was not clear cut in this study. It is possible that within the P2 region there may be two shorter regions of deletion: one between the markers D8S259-D8S513 and the other between D8S505 and D8S87. This cannot be substantiated by clinical correlation because of the diminishing number of tumours in each subgroup. It is also possible that this discrepancy represents a localized chromosomal rearrangement. The ®nding that P2 deletions are strongly associated with one tumour phenotype would tend to implicate a single gene in this region.
The low frequency of P2 deletions in more advanced colorectal cancers was a surprising ®nding that does not ®t easily into classical models of molecular tumorigenesis. One would usually expect a mutational event to increase in frequency, up to a plateau, as more advanced tumours are analysed. The ®nding of an interstitial deletion which reduces in frequency in more advanced tumours clearly warrants further study. In situ hybridization studies could identify the presence of a subclone of P2 deleted tumour cells, which may be subsequently overgrown by a more rapidly proliferating cell line. It may be however, that deletion of a gene (or genes) in the P2 region is in some way protective against rapidly progressive disease. This particular mutational event would appear to be most common in tumours that develop from large tubulovillous adenomas. Further studies are required to clarify the mutational events at the P2 locus, before a positional cloning strategy could be successfully employed.
In the current study, the shortest region of deletion identi®ed was between the markers D8S255 and ANK-1 (P1 region) which may represent a region as small as 1 cM (Dib et al., 1996) . The FISH studies have con®rmed this to be a true interstitial deletion. These data provide sucient localization for positional cloning of candidate tumour suppressor gene within the P1 region.
A number of candidate genes have been mapped to and isolated from the 8p11-p12 region which includes the P2 region. Earlier studies mapped DNA polymerase b, a DNA repair enzyme (Cannizaro et al., 1987) to 8p11-p12 and the b isoform of the catalytic subunit of protein phosphatase 2A (PPP2CB) (Jones et al., 1993) to 8p11.2-p12. Mutations in DNA polymerase b were initially reported in both colorectal and prostate tumours (Wang et al., 1992; Dobashi et al., 1994) but subsequent studies have refuted these ®ndings (Eydmann and Knowles, 1997). It seems likely that the presumed mutations in DNA polymerase b were splice site variants (Chyan et al., 1994) . No mutations in the PPP2CB gene have been documented (Eydmann and Knowles, 1997) . Extensive mapping of the 8p11-p12 region (Dib et al., 1995; Imbert et al., 1996) has recently led to the isolation of the Werner syndrome (WRN) gene (Yu et al., 1996) . This syndrome is associated with early onset ageing, and a predisposition to tumours, making it a strong candidate gene. We have investigated this using a polymorphic marker to the Werner's gene locus but have not identi®ed a high frequency of deletions in our tumours (unpublished data). The gene appears to lie at the telomeric end of the P2 region. Linkage analysis of breast cancer families unlinked to the BRCA1 or BRCA2 genes has suggested the BRCA3 gene may also lie in this region (Imbert et al., 1996) . During the search for the Werner syndrome gene (WS), a further three novel genes have been localized to this region; RBP-MS (8p11-p12) (Shimamoto et al., 1996) , WS-3 (8p11-p12) and Rep-8 (8p11.2-p12) . No functional roles for these novel genes have been reported. This study has produced a detailed deletion map of the 8p11.2-p12 region in colorectal cancers. The in situ hybridization studies on the P1 region have substantiated these ®ndings. In addition, the identi®cation of a functional relationship between the individual deletion sites and tumour behaviour indicates that genes of functional signi®cance for a number of solid tumours are present at these sites.
Materials and methods

Patients and samples
Fresh primary adenocarcinoma biopsies were taken at surgery from 70 consecutive patients with colorectal cancer (Table 1) and a further 11 patients with colorectal adenomas. A representative sample was taken from the luminal surface of each tumour. Tumours were staged according to the TNM classi®cation (Hermanek and Sobin, 1987) . The tumour samples were snap frozen in liquid nitrogen, and a representative sample was also taken for histopathological assessment in order to determine the percentage of tumour cells in each sample. Each sample retained for the present study contained more than 70% tumour cells. Ten ml of venous blood was collected as a source of leukocytes and stored at 7208C in EDTA tubes for subsequent DNA extraction.
Histopathology reports were reviewed for each patient for information on the grade and stage of the tumour. Vascular, lymphatic and perineural microinvasion was assessed by a single pathologist on the ®rst 22 cases. Clinical information was collected on the type of operation performed, the site of the tumour, the absence or presence of liver metastasis, the gender and the age of the patient at the time of diagnosis.
DNA extraction
DNA was obtained from frozen tumour samples as previously described (Goelz et al., 1985) . Constitutional DNA was obtained from peripheral blood leukocytes by use of the Nucleon Kit (Scotlab BioScience, Lanarkshire, Scotland). DNA was resuspended in Tris/EDTA (TE) buer.
Microsatellite markers
Eleven microsatellite markers to the short arm of chromosome 8 were used. Primer sequences for these markers were obtained from the genome database. Eight primer pairs to the 8p11.2-p12 region were used. In addition, primers to the 8p22-pter region were used so whole arm loss could be inferred. The linkage order of these markers has been established as telomere-D8S201-LPL GZ-NEFL-D8S278-D8S259-D8S513-D8S505-D8S87-D8S255-ANK-1-PLAT-centromere, as con®rmed by the Genome Database. Single primer strands were end-labelled with g 32 P-dATP (ICN Pharmaceuticals, Inc., California, USA) using T4 polynucleotide kinase (NBL Gene Sciences Ltd., Northumberland, UK) (Berkner and Folk, 1997) . Each PCR mix was made up to a total volume of 12.5 ml and included, 70 ng/ml of each primer (one end-labelled), and IU of Supertaq DNA polymerase (HT Biotechnology Ltd., Cambridge, UK), and 0.5 ml of genomic DNA (10 ng/ ml). PCR conditions were 958C for 8 min, then 27 cycles at 958C for 30 s, 558C for 1 min and 728C for 1 min 30 s followed by a ®nal extension for 10 min at 728C.
Denaturing polyacrylamide gels
A 7.5 ml aliquot of formamide loading buer (0.5 M EDTA pH8, 10 mg bromophenol blue, 10 mg xylene cyanol) was mixed with the labelled ampli®ed DNA. The samples were denatured for 3 min at 808C and resolved on 0.4 mm 6% denaturing polyacrylamide gels (Flowgen Instruments Ltd., Kent, UK). Gels were ®xed in methanol/acetic acid for 15 min before transferring to Whatman ®lter paper. Autoradiography was performed for 12 ± 48 h.
Interpretation of loss
LOH was interpreted from all informative (heterozygous) cases by two independent observers. Loss was recorded if there was a clear visual reduction in the band intensity of one of the tumour alleles, or a complete absence of one of the bands in the tumour DNA in comparison to the homologous allele in the normal DNA. LOH was evaluated in each case without reference to the clinicopathological information. Equivocal ®ndings were repeated and analsyed by Ultroscan XL laser densitometry (LKB, Bromma, Sweden). LOH was assumed if laser densiometry showed a reduction in intensity of 50% or more in one allele. Samples were categorized as no loss, allelic loss, allelic imbalance or not informative.
Statistical methodology
Categorical data were analysed by the two-tailed Fishers' Exact Probability Test with signi®cance set at the 5% level.
Touch-prep preparation of tumour material for¯uorescent in situ hybridization (FISH) At the time of touch-prep (or tumour imprint) preparation, the tumour tissue was thawed and blotted on ®lter paper (Whatman 3M) before touching onto silanized microscope slides. The touch-preps were immediately ®xed for 30 min in methanol:acetic acid (3 : 1), air-dried and stored at 7208C until used.
Probe preparations and hybridization
For chromosome 8 enumeration, a centromere speci®c alpha-satellite repeat probe D8Z2 (kindly provided by Hunt Willard) was used. Two speci®c bacteriophage P1 clones RMC-08P-044 positive for the microsatellite D8S255 and RMC-08P-049 positive for ANK-1 (kindly supplied by the Lawrence Berkeley Resource for Molecular Cytogenetics, San Francisco, USA) were used for deletion analysis. The speci®c STS content was con®rmed by PCR analysis and their locus at 8p11.2-p12 was con®rmed using FISH to a normal lymphocyte metaphase preparation.
The chromosome 8 centromere probe D8Z2 was labelled by nick translation with digoxigenin-11-dUTP (Boehringer Mannheim) while the sequence speci®c probes were labelled similarly with biotin-16-dUTP (Boehringer Mannheim). Unincorporated nucleotide was removed by ethanol precipitation and resuspended in 10 ml Tris-EDTA buer.
Prior to hybridization, the slides were denatured in 70% formamide-26SSC (pH 7.4) at 708C for 2 min and quenched in 70% ethanol. The hybridization mix consisted of 10 ml hybridization buer (50% demonized formamide, 26SSC, 10% dextran sulphate, 0.1% SDS, 16Denhardt's solution, 40 mM sodium phosphate pH 7), 50 ng (0.5 ml) of labelled D8Z2, 150 ng (1.5 ml) of labelled sequence-speci®c probe, and 1.5 mg Cot-1 DNA (Gibco-BRL). This was denatured and then allowed to pre-anneal for 30 min at 378C. The probes were then applied to the slide, covered with a cover slip and sealed with rubber solution. The slide was incubated in a humid chamber at 378C overnight. After the coverslips were soaked o, the slides were preblocked with 3% bovine serum albumin (Sigma). Detection of biotin and digoxigenin labelled probes was undertaken simultaneously. For the ®rst layer, the slides were incubated for 20 min at 378C with FITC-conjugated mouse antidigoxigenin (Sigma) and avidin-Cy3 (Amersham) in 46SSC/5% total non-fat milk powder (Marvel)/0.05% Tween under Nesco®lm. After 365 min washes in 46SSC/5% Marvel/0.05% Tween at 378C, the second layer was applied with FITC-conjugated rabbit anti-mouse (Sigma) and goat anti-avidin. After a further three washes, a ®nal layer of avidin-Cy3 was applied before a ®nal three washes was carried out. The slides were then counterstained in DAPI (0.5 mg/ml in 26SSC) for 2 min, rinsed and dehydrated in ethanol.
Visualization and quantitation
A Nikon Labophot¯uorescence microscope was used. Where signal loss was suspected, the cell was examined using a dual red-green ®lter. Cells were also randomly checked for signal counts using a highly sensitive cooled charge-coupled device (CCD) camera with digital image analysis. Cells with physical deletion of the target sequence was de®ned as those in which there were fewer Cy3 signals than FITC signals. Only cells which were non-overlapping and which appeared intact were counted. Cells with no Cy3 signals were discounted as were cells with only one Cy3 and one FITC signal. While the former situation may represent cells with homozygous deletions and the latter monosomy of chromosome 8; we elected to use a more stringent set of criteria than those employed in previous published FISH studies in order to limit any`false positives' for deletion scoring.
Abbreviations LOH, loss of heterozygosity; PCR, polymerase chain reaction; FISH,¯uorescent in situ hybridization.
